These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 30699493

  • 21. Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.
    Higuchi T, Soga Y, Muro M, Kajizono M, Kitamura Y, Sendo T, Sasaki A.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):547-551. PubMed ID: 29574058
    [Abstract] [Full Text] [Related]

  • 22. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
    Kubo N, Katayama K, Ishizaki A, Morinaga N, Negishi T, Kuwano H.
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
    [Abstract] [Full Text] [Related]

  • 23. Drug-induced osteonecrosis of the jaw: the state of the art.
    Fassio A, Bertoldo F, Idolazzi L, Viapiana O, Rossini M, Gatti D.
    Reumatismo; 2017 May 22; 69(1):9-15. PubMed ID: 28535616
    [Abstract] [Full Text] [Related]

  • 24. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar 22; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 25. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G.
    Oral Oncol; 2008 Sep 22; 44(9):857-69. PubMed ID: 18282788
    [Abstract] [Full Text] [Related]

  • 26. Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.
    Haidar A, Jønler M, Folkmar TB, Lund L.
    Scand J Urol Nephrol; 2009 Sep 22; 43(6):442-4. PubMed ID: 19903091
    [Abstract] [Full Text] [Related]

  • 27. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA, López Tarruella S, García Paredes B, Rodríguez Lajusticia L, Villalobos L, Díaz Rubio E.
    Med Oral Patol Oral Cir Bucal; 2007 Sep 01; 12(5):E351-6. PubMed ID: 17767097
    [Abstract] [Full Text] [Related]

  • 28. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.
    J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620
    [Abstract] [Full Text] [Related]

  • 29. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.
    Rachner TD, Platzbecker U, Felsenberg D, Hofbauer LC.
    Mayo Clin Proc; 2013 Apr 01; 88(4):418-9. PubMed ID: 23541016
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C, Al-Nawas B, du Bois A, Buch L, Harter P, Grötz KA.
    Cancer; 2009 Apr 15; 115(8):1631-7. PubMed ID: 19156913
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis.
    Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, Häuselmann H, Studer U, Ziswiler HR, Reichenbach S, Lehmann T.
    J Bone Miner Res; 2022 Feb 15; 37(2):340-348. PubMed ID: 34787342
    [Abstract] [Full Text] [Related]

  • 36. Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw.
    Troeltzsch M, Woodlock T, Kriegelstein S, Steiner T, Messlinger K, Troeltzsch M.
    J Can Dent Assoc; 2012 Feb 15; 78():c85. PubMed ID: 22985897
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. New Non-Bisphosphonate Drugs that Produce Osteonecrosis of the Jaws.
    Ramírez L, López-Pintor RM, Casañas E, Arriba Ld, Hernández G.
    Oral Health Prev Dent; 2015 Feb 15; 13(5):385-93. PubMed ID: 25884045
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.